🩺 OBSERVED/INTERACTIVE STATION · CPSP FORMAT · 7 MINUTES · STEP-DOWN ASTHMA · TWO CLINICAL SCENARIOS
📖 Two Problem-oriented Clinical Scenarios – Well-Controlled Asthma
👧🏻 SCENARIO 1 (6-year-old):
A 6-year-old with persistent asthma has been on low-dose ICS (inhaled corticosteroid) for 3 months. He is now well-controlled: daytime symptoms ≤2 days/week, no nighttime awakenings, SABA use ≤2 days/week, normal activity, no exacerbations. Spirometry normal. Mother asks if she can stop the inhaler.
Task 1: What is the next step? When and how to step down therapy?
🧑🏻 SCENARIO 2 (15-year-old):
A 15-year-old with severe persistent asthma has been on high-dose ICS/LABA + LAMA (tiotropium) + oral montelukast for 3 months. He is now well-controlled (ACT score 24, no exacerbations, normal lung function). He is bothered by the number of daily medications and wants to reduce.
Task 2: What is the appropriate step-down approach in a patient on high-dose triple therapy?
📉 Key Principle (Nelson Ch.185): Once asthma is well-controlled for ≥3 months, step down therapy to the lowest effective dose. Step down by 25-50% ICS dose or discontinue add-on medications one at a time. Reassess in 2-6 weeks.
💡 Examiner instruction: Candidate must demonstrate knowledge of step-down timing (after 3 months of good control), order of removing controllers (add-ons first, then reduce ICS), and monitoring after step-down. For Scenario 2: cannot abruptly stop high-dose ICS – step down systematically.
❓ Q1 (Examiner): “In Scenario 1 (6-year-old on low-dose ICS well-controlled for 3 months), what is the next step?”
✅ Step down to lowest effective dose – but do NOT stop ICS completely if persistent asthma. Options (per NAEPP/GINA):
• Reduce ICS dose by 25-50% (e.g., fluticasone 88 mcg BID → 44 mcg BID).
• If on once-daily ICS, consider reducing frequency (e.g., every other day) – but not preferred.
• Continue as-needed SABA for rescue.
• Reassess control in 2-6 weeks.
Complete withdrawal of ICS in persistent asthma increases risk of exacerbation.
❓ Q2 (Examiner): “How long must asthma be well-controlled before considering step-down?”
✅ Minimum 3 months of good control (well-controlled by NAEPP criteria: daytime symptoms ≤2 days/week, nocturnal ≤2x/month, SABA ≤2 days/week, no exacerbations, normal FEV1). Step-down earlier may lead to loss of control.
❓ Q3 (Examiner): “In Scenario 2 (15-year-old on high-dose ICS/LABA + LAMA + montelukast, well-controlled), what is the step-down order?”
✅ Step-down in reverse order of addition:
1️⃣ First, discontinue LAMA (tiotropium) or montelukast (one at a time, monitor for 2-4 weeks).
2️⃣ If still controlled, reduce ICS/LABA to medium-dose.
3️⃣ If controlled on medium-dose ICS/LABA, consider switching to low-dose ICS/LABA or ICS alone.
• Do not stop LABA without ICS (risk of exacerbation).
• Reassess after each step-down.
❓ Q4 (Examiner): “Why can’t you just stop high-dose ICS abruptly in Scenario 2?”
✅ Abrupt withdrawal of high-dose ICS can lead to adrenal insufficiency (if prolonged high-dose) and rapid loss of asthma control with rebound airway inflammation, potentially precipitating a severe exacerbation. Step-down must be gradual over weeks to months.
❓ Q5 (Examiner): “How do you monitor a patient after step-down?”
✅ • Follow-up in 2-6 weeks (phone or clinic).
• Assess symptom frequency, SABA use, ACT score, peak flow variability.
• Spirometry at follow-up visit.
• If loss of control (symptoms increase, FEV1 decline, exacerbation), step back up to previous effective dose.
❓ Q6 (Examiner): “What is the lowest effective dose of ICS for a 6-year-old with persistent asthma?”
✅ Examples of low daily doses for age 5-11 years (NAEPP):
• Fluticasone MDI: 88 mcg (44 mcg BID)
• Budesonide DPI: 180 mcg daily
• Mometasone DPI: 110 mcg daily
• Beclomethasone MDI: 80-160 mcg
The lowest effective dose is the minimum that maintains control without exacerbations.
❓ Q7 (Examiner): “When can you consider discontinuing daily ICS altogether in a child with persistent asthma?”
✅ Only after a period of ≥3-6 months on minimal ICS dose with excellent control and no exacerbations. Even then, many children require low-dose ICS to maintain control. Complete discontinuation may be attempted in spring/summer (if seasonal triggers low), but monitor closely. In many persistent asthma, ICS cannot be stopped entirely without relapse.
✅ • Mild-moderate baseline severity.
• No recent exacerbations (≥6-12 months).
• Normal lung function (FEV1 ≥80%).
• Low FeNO, low blood eosinophils (type 2 inflammation controlled).
• Absence of allergen sensitization or good environmental control.
• Good adherence and ability to monitor symptoms.
❓ Q9 (Examiner): “Can you step down from ICS/LABA to ICS alone without losing control?”
✅ Yes, in patients well-controlled on low-to-medium dose ICS/LABA, discontinuing LABA while continuing the same dose of ICS is recommended to minimize LABA risk. However, some patients may have loss of control. Step down by: ICS/LABA → same dose ICS alone → monitor for 2-4 weeks. If deterioration, resume ICS/LABA.
❓ Q10 (Examiner): “How does step-down differ in preschool children (age <5 years) vs older children?”
✅ In preschoolers, many have intermittent viral wheeze (not persistent atopy-associated asthma). Step-down after 3 months well-controlled: reduce ICS to lowest effective dose (e.g., budesonide nebulized 0.5 mg daily). Many can discontinue ICS during symptom-free intervals (summer). However, poor growth in young children on ICS requires careful step-down.
❓ Q11 (Examiner): “What is the role of seasonal step-down (e.g., summer) in asthma management?”
✅ For patients with seasonal allergic asthma (e.g., fall pollen triggers), it is reasonable to step down ICS in summer (low trigger season) and step up before the season. This is called seasonal adjustment. However, avoid complete withdrawal if persistent year-round symptoms. For patients with perennial triggers, step-down is based on control, not season.
❓ Q12 (Examiner): “How do you counsel the 15-year-old who wants to stop all medications because he ‘feels fine’?”
✅ Explain that his good control is due to current medications. Abrupt stop risks severe exacerbation. Propose a step-down plan: first stop montelukast or LAMA, then after 4 weeks reduce ICS/LABA, but will likely still need daily controller. Emphasize that the goal is lowest effective dose, not zero medications. Engage adolescent in shared decision-making, address steroid phobia, and provide written action plan.
🗣️ Examiner high-yield pearls (Step-Down Therapy):
• Do NOT step down before 3 months of well-controlled asthma.
• Reduce ICS by 25-50% or discontinue add-ons one at a time.
• Monitor for loss of control in 2-6 weeks; if lost, step back up.
• Complete ICS withdrawal is rarely appropriate in persistent asthma.
• In adolescent on triple therapy: remove LAMA or LTRA first, then reduce ICS/LABA dose.
📘 Step-Down Therapy for Well-Controlled Asthma (Nelson Ch.185)
Step-Down Strategy
6-year-old (Step 2 → Step 1/2)
15-year-old (Step 5 → Step 4/3)
Timing
After ≥3 months well-controlled
First step
Reduce ICS dose 25-50% (e.g., 88→44 mcg BID)
Discontinue add-on: stop LAMA or montelukast
Second step
Consider once-daily ICS or lowest available dose
Reduce ICS/LABA from high → medium dose
Third step
Attempt ICS discontinuation only if very mild intermittent
Medium-dose ICS/LABA → low-dose ICS/LABA or ICS alone
Monitoring
Follow-up at 2-6 weeks; if loss of control → return to previous step
⭐ High-yield for TOACS (Step-Down):
✔ Rule of 3 months: Well-controlled for 3 months → step down.
✔ Gradual reduction: 25-50% reduction in ICS every 3 months if control persists.
✔ Add-ons first: Discontinue LABA, LAMA, or LTRA before reducing ICS.
✔ Never stop LABA without ICS (risk of severe exacerbation).
✔ Watch for adrenal insufficiency when stepping down high-dose ICS after prolonged use.
🗣️ Candidate Role‑Play & Examiner Feedback
💬 To the candidate (role-play): You will see two patients. For the 6-year-old's mother: explain that her son’s asthma is well-controlled but he still has persistent asthma – we will reduce the dose by half, not stop completely. For the 15-year-old: he is frustrated with many medications – propose a step-down plan removing montelukast first, then reducing ICS/LABA dose. Emphasize monitoring for symptoms after each reduction.
🗣️ Sample candidate scripts: For 6-year-old: “Your son’s asthma is very well-controlled, which is great. Since it’s been 3 months, we can reduce his daily inhaler dose by half – from 88 mcg to 44 mcg twice a day. But he still needs to stay on it because asthma is a chronic condition. If he stays well-controlled for another few months, we might try once-daily dosing. I want to see him in 4 weeks to check.” For 15-year-old: “I understand you want to take fewer medications. Because your asthma has been stable for 3 months, we can step down. First, let’s stop the montelukast tablet. Keep your high-dose ICS/LABA and LAMA. In 4 weeks, if you remain well-controlled, we will reduce your ICS/LABA to medium-dose. Do not stop anything suddenly – that could trigger a severe attack.”
📚 References: Nelson Textbook of Pediatrics 22e, Chapter 185 (Childhood Asthma); NAEPP 2020 Focused Updates; GINA 2024 step-down recommendations.